Skip to Main Content

Advertisement

Skip Nav Destination

Immunotherapy Is Active in MMR-Deficient and MMR-Proficient Colon Cancer

Cancer Discov (2020) 10 (6): 760.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal